Health
Immune cells in cerebrospinal fluid could be novel biomarkers to immune-based therapies – News-Medical.Net
Results from a study led by Joan Seoane, Director of Preclinical and Translational Research co-program at VHIO and ICREA Professor, show that immune cells accessing…
Results from a study led by Joan Seoane, Director of Preclinical and Translational Research co-program at VHIO and ICREA Professor, show that immune cells accessing cerebrospinal fluid faithfully recapitulate the characteristics of cells identified in brain metastasis, and could therefore constitute novel biomarkers of response to immune-based therapies.
Immune checkpoint inhibitors including anti-PD1, anti-PD-L1, and anti-CTLA4, have shown significant clinical benefits in patients with progressive…
-
General9 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News18 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News11 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General24 hours agoWest Indies vs Australia live: Second Test, day three from Grenada